Victory Capital Management
PASG icon

Victory Capital Management’s Passage Bio PASG Stock Holding History

Victory Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,353
Closed -$888K – 2827
2021
Q2 		$888K Sell
3,353
-1,695
-34% -$524K ﹤0.01% 1938
2021
Q1 		$1.76M Sell
5,048
-123
-2% -$52.5K ﹤0.01% 1680
2020
Q4 		$2.65M Buy
5,171
+2,337
+82% +$936K ﹤0.01% 1430
2020
Q3 		$743K Sell
2,834
-434
-13% -$149K ﹤0.01% 1827
2020
Q2 		$1.79M Sell
3,268
-17,663
-84% -$7.94M ﹤0.01% 1476
2020
Q1 		$6.59M Buy
+20,931
New +$6.55M 0.01% 1193

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management's PASG Position: Q3 2021 in Review

Victory Capital Management sold out of Passage Bio (PASG) in Q3 2021, closing a stake of 3,353 shares — an estimated $888K sold.

Victory Capital Management first reported a position in PASG in Q1 2020 and held it in 6 quarters. The position peaked at $6.59M in Q1 2020. 101 funds tracked by Wall St. Rank hold PASG as of Q3 2021.

  • Victory Capital Management reported no remaining Passage Bio position as of Q3 2021 after selling out during the quarter.
  • Victory Capital Management sold 3,353 Passage Bio shares in Q3 2021, an estimated $888K.
  • Victory Capital Management first reported a position in Passage Bio in Q1 2020 and held it in 6 quarters.
  • Victory Capital Management's Passage Bio position peaked at $6.59M in Q1 2020.
  • 101 funds tracked by Wall St. Rank held Passage Bio as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.